News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,747 Results
Type
Article (8264)
Company Profile (8)
Press Release (175470)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (57889)
Career Advice (526)
Deals (10335)
Drug Delivery (23)
Drug Development (24510)
Employer Resources (31)
FDA (4246)
Job Trends (4412)
News (94867)
Policy (7380)
Tag
Academia (475)
Accelerated approval (5)
Adcomms (4)
Allergies (48)
Alliances (7277)
ALS (62)
Alzheimer's disease (500)
Antibody-drug conjugate (ADC) (75)
Approvals (4382)
Artificial intelligence (165)
Autoimmune disease (24)
Automation (11)
Bankruptcy (110)
Best Places to Work (3987)
BIOSECURE Act (3)
Biosimilars (70)
Biotechnology (12)
Bladder cancer (79)
Brain cancer (19)
Breast cancer (237)
Cancer (1849)
Cardiovascular disease (145)
Career advice (430)
Career pathing (1)
CAR-T (92)
CDC (4)
Cell therapy (246)
Cervical cancer (15)
Clinical research (22449)
Collaboration (526)
Company closure (1)
Compensation (391)
Complete response letters (10)
COVID-19 (717)
CRISPR (29)
C-suite (162)
Cystic fibrosis (38)
Data (2109)
Depression (29)
Diabetes (181)
Diagnostics (1864)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (57)
Drug pricing (28)
Drug shortages (6)
Duchenne muscular dystrophy (68)
Earnings (46672)
Editorial (11)
Employer branding (5)
Employer resources (27)
Events (29565)
Executive appointments (380)
FDA (5390)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (493)
Gene editing (65)
Generative AI (5)
Gene therapy (185)
GLP-1 (373)
Government (1165)
Grass and pollen (4)
Guidances (300)
Healthcare (5267)
HIV (26)
Huntington's disease (9)
IgA nephropathy (20)
Immunology and inflammation (76)
Immuno-oncology (6)
Indications (22)
Infectious disease (818)
Inflammatory bowel disease (75)
Inflation Reduction Act (1)
Influenza (41)
Intellectual property (55)
Interviews (93)
IPO (6685)
IRA (8)
Job creations (712)
Job search strategy (380)
Kidney cancer (12)
Labor market (18)
Layoffs (154)
Leadership (3)
Legal (1396)
Liver cancer (32)
Longevity (4)
Lung cancer (294)
Lymphoma (159)
Machine learning (9)
Management (10)
Manufacturing (170)
MASH (50)
Medical device (3706)
Medtech (3711)
Mergers & acquisitions (4017)
Metabolic disorders (459)
Multiple sclerosis (59)
NASH (7)
Neurodegenerative disease (65)
Neuropsychiatric disorders (15)
Neuroscience (869)
NextGen: Class of 2025 (1412)
Non-profit (1046)
Now hiring (13)
Obesity (228)
Opinion (46)
Ovarian cancer (52)
Pain (61)
Pancreatic cancer (69)
Parkinson's disease (90)
Partnered (3)
Patents (104)
Patient recruitment (114)
Peanut (27)
People (6162)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase I (5905)
Phase II (9437)
Phase III (8758)
Pipeline (1732)
Policy (31)
Postmarket research (954)
Preclinical (1948)
Press Release (12)
Prostate cancer (95)
Psychedelics (8)
Radiopharmaceuticals (85)
Rare diseases (215)
Real estate (913)
Recruiting (12)
Regulatory (5976)
Reports (16)
Research institute (444)
Resumes & cover letters (88)
Rett syndrome (9)
RNA editing (2)
RSV (35)
Schizophrenia (55)
Series A (78)
Series B (58)
Service/supplier (1)
Sickle cell disease (37)
Special edition (8)
Spinal muscular atrophy (71)
Sponsored (10)
Startups (593)
Stomach cancer (4)
Supply chain (37)
Tariffs (14)
The Weekly (7)
Vaccines (309)
Venture capital (23)
Weight loss (150)
Women's health (16)
Worklife (5)
Date
Today (38)
Last 7 days (221)
Last 30 days (1001)
Last 365 days (16637)
2025 (11700)
2024 (13654)
2023 (12586)
2022 (16376)
2021 (16028)
2020 (14213)
2019 (12463)
2018 (9249)
2017 (8431)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
Location
Africa (195)
Alabama (16)
Alaska (2)
Arizona (51)
Arkansas (4)
Asia (11079)
Australia (1843)
California (4285)
Canada (1112)
China (373)
Colorado (171)
Connecticut (213)
Delaware (167)
Europe (26731)
Florida (495)
Georgia (131)
Hawaii (2)
Idaho (17)
Illinois (341)
India (12)
Indiana (178)
Iowa (7)
Japan (174)
Kansas (27)
Kentucky (12)
Louisiana (9)
Maine (27)
Maryland (433)
Massachusetts (3252)
Michigan (84)
Minnesota (214)
Mississippi (3)
Missouri (48)
Montana (7)
Nebraska (2)
Nevada (60)
New Hampshire (25)
New Jersey (1211)
New Mexico (7)
New York (1107)
North Carolina (460)
North Dakota (5)
Northern California (1956)
Ohio (111)
Oklahoma (5)
Oregon (8)
Pennsylvania (744)
Puerto Rico (3)
Rhode Island (10)
South America (289)
South Carolina (8)
Southern California (1576)
Tennessee (65)
Texas (669)
United States (14860)
Utah (109)
Virginia (113)
Washington D.C. (18)
Washington State (339)
West Virginia (2)
Wisconsin (62)
183,747 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ruvidar Demonstrates 7 Year Complete Response
Patient Diagnosed with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ Treated Once with Light-Activated Ruvidar(TM) Demonstrates 7 Year Complete Response
April 7, 2025
·
6 min read
Job Trends
7 Companies Hiring in North Carolina
Looking for a biopharma job in North Carolina? Check out the
BioSpace
list of seven companies hiring life sciences professionals like you.
July 31, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Elicio Therapeutics Reports ELI-002 7P Achieved Robust mKRAS-Specific T Cell Responses in 99% of Evaluable Patients in Ongoing Phase 2 AMPLIFY-7P Trial
September 18, 2025
·
11 min read
Press Releases
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
August 21, 2025
·
2 min read
Press Releases
L7 Informatics Affirms Architecture, Not Data, is the True Moat for AI in Life Sciences
September 12, 2025
·
1 min read
Press Releases
Innovative Medicine Market to Reach US$ 427.20 Billion by 2032, Growing at a 7.7% CAGR, Driven by Chronic Disease Prevalence and R&D Investment
August 11, 2025
·
1 min read
Press Releases
Regeneron Announces Investor Conference Presentations - August 7, 2025
August 8, 2025
·
1 min read
Press Releases
Traditional Medicine Market Size to Hit USD 359.37 by 2032 at Robust 7.7% CAGR | Coherent Market Insights
July 10, 2025
·
1 min read
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
Novartis and Monte Rosa first partnered in October 2024 for a molecular glue asset for immune-mediated and autoimmune diseases. This time, the pharma is putting $120 million down upfront for more of the biotech’s AI-discovered degraders.
September 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cytokinetics to Announce Second Quarter Results On August 7, 2025
July 24, 2025
·
3 min read
1 of 18,375
Next
